SCHEMBL13679017

SCHEMBL13679017

Cc1nc(-c2ccc(C(F)(F)F)cc2)oc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.53
IKBKB O14920 1/20 0.51
LMNA P02545 1/20 0.50
THRB P10828 1/20 0.50
PPARD Q03181 5/20 0.48
PPARG P37231 3/20 0.48
NOTUM Q6P988 1/20 0.46
PPARA Q07869 3/20 0.44
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NPC1 O15118 2/20 0.43
KIF11 P52732 1/20 0.42
UTRN P46939 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1868373 0.83 PTPN1 (0.51) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL20861471 0.80 PPARA (0.53) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL2517496 0.80 PPARA (0.49) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL6221689 0.80 PTPN1 (0.49) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL12151275 0.80 PPARD (0.56) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL5543997 0.79 NPC1 (0.52) NOTUMNPC1KDM4EHPGDRAB9A
SCHEMBL3737979 0.79 IKBKB (0.49) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL4432682 0.79 IKBKB (0.49) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL2245562 0.79 PPARD (0.55) PTPN1IKBKBLMNATHRBPPARD
SCHEMBL9831925 0.79 PTPN1 (0.51) PTPN1IKBKBLMNATHRBPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638963-B1 N-ACYL NITROGEN HETEROCYCLES AS LIGANDS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS NOVARTIS AG (CH) 2009-09-09 EP disclosed
EP-1448523-B1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE NOVARTIS AG (CH) 2007-08-22 EP disclosed